Health & Fitness
Mon, April 4, 2011Sun, April 3, 2011Sat, April 2, 2011Fri, April 1, 2011Thu, March 31, 2011Wed, March 30, 2011Tue, March 29, 2011Mon, March 28, 2011Sun, March 27, 2011Fri, March 25, 2011Thu, March 24, 2011Wed, March 23, 2011Tue, March 22, 2011Mon, March 21, 2011Sun, March 20, 2011Fri, March 18, 2011Thu, March 17, 2011Wed, March 16, 2011Tue, March 15, 2011Mon, March 14, 2011West and CareFusion Announce Plans to Develop an Innovative Needle-Free Vented Vial Access Device
//health-fitness.news-articles.net/content/2011/ .. ative-needle-free-vented-vial-access-device.html
Published in Health and Fitness on Thursday, March 24th 2011 at 5:15 GMT by Market Wire🞛 This publication is a summary or evaluation of another publication
LIONVILLE, Pa.--([ BUSINESS WIRE ])--West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative system and component solutions for [ injectable drug administration ], and CareFusion, (NYSE: CFN), a global medical technology company, today announced they will jointly develop and market a new, needle-free vial access device. This initiative is part of a five year global distribution and supply agreement between the two companies.
"West is pleased to offer its vented vial adapter technology with CareFusion to develop safer products for patients and caregivers. This new vented-vial access system can be used for transportation, reconstitution and administration of hazardous substances such as chemotherapy, antivirals and other cytotoxic drug products"
The new product, which will be available in late 2011, is intended not only to help prevent leaks, but also reduce surface contamination and risk of exposure during a drug producta™s [ reconstitution ] process. The system will be based on Westa™s vented [ vial adapter ] in combination with CareFusiona™s needle-free connector and closed male luer technologies.
aWest is pleased to offer its vented vial adapter technology with CareFusion to develop safer products for patients and caregivers. This new vented-vial access system can be used for transportation, reconstitution and administration of hazardous substances such as chemotherapy, antivirals and other cytotoxic drug products,a said Glen Zimmermann, associate director marketing, West Administration Systems, Americas. aWe look forward to working with CareFusion on future development projects.a
aThe safety of health care workers is one of our primary concerns,a said Bob Tolliver, director of OEM business development, Infusion for CareFusion. aThis innovative component will be a strong addition to our existing portfolio designed to help protect clinicians from accidental exposure to hazardous drugs.a
The product development is part of a distribution and development agreement that was signed in September 2010. The agreement provides West with exclusive worldwide rights to sell the Texium® closed male luer to pharmaceutical companies and contract manufacturers as part of a drug kit. West also obtains non-exclusive rights to sell SmartSite® in conjunction with Texium.
The agreement further provides CareFusion, which sells products and services to hospitals around the world, with exclusive worldwide rights to sell the new vented-vial access device on a standalone basis to hospital, physician and pharmacy customers. In addition, CareFusion plans to replace its current vented-vial product with the new, jointly developed product.
About West
Westa™s innovative system, device and [ component solutions ] help improve the safety and administration of injectable drugs. Westa™s proprietary materials science, formulation research and manufacturing technologies advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics and vaccines. West supports its customers from facilities in North and South America, Europe, Asia and Australia. For more information, visit [ www.westpharma.com ]. Follow us on Twitter: [ www.twitter.com/WestPharma ].
About CareFusion Corporation
CareFusion is a global corporation serving the health care industry with products and services that help hospitals measurably improve patient care. The company develops market-leading technologies including Alaris® infusion pumps, Pyxis® automated dispensing and patient identification systems, AirLifea", AVEA® and LTV® series of ventilators and respiratory products, ChloraPrep® skin prep products, MedMineda" services for data mining surveillance, V.Mueller® and Snowden-Pencer® surgical instruments and NeuroCare diagnostic products. CareFusion employs more than 15,000 people across its global operations. More information may be found at [ www.carefusion.com ].
